1921
Volume 99, Issue 2
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645
Preview this article:
Zoom in
Zoomout

The Potential for Testing Stool to Reduce Tuberculosis Missed Diagnoses and Misdiagnoses, Page 1 of 1

| /docserver/preview/fulltext/14761645/99/2/tpmd180507-1.gif

There is no abstract available for this article.
Use the preview function to the left.

[open-access] This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.18-0507
2018-08-02
2018-08-16
Loading full text...

Full text loading...

/deliver/fulltext/14761645/99/2/tpmd180507.html?itemId=/content/journals/10.4269/ajtmh.18-0507&mimeType=html&fmt=ahah

References

  1. Evans CA, , 2011. GeneXpert—a game-changer for tuberculosis control? PLoS Med 8: e1001064.
  2. McCarthy K, Fielding K, Churchyard GJ, Grant AD, , 2018. Empiric tuberculosis treatment in South African primary health care facilities—for whom, where, when and why: implications for the development of tuberculosis diagnostic tests. PLoS One 13: e0191608.
  3. Wingfield T, Boccia D, Tovar M, Gavino A, Zevallos K, Montoya R, Lönnroth K, Evans CA, , 2014. Defining catastrophic costs and comparing their importance for adverse tuberculosis outcome with multi-drug resistance: a prospective cohort study, Peru. PLoS Med 11: e1001675.
  4. Martinson NA, Karstaedt A, Venter WF, Omar T, King P, Mbengo T, Marais E, McIntyre J, Chaisson R, Hale M, , 2007. Causes of death in hospitalized adults with a premortem diagnosis of tuberculosis: an autopsy study. AIDS 21: 20432050.
  5. Moore DAJ, 2006. Microscopic-observation drug-susceptibility assay for the diagnosis of TB. N Engl J Med 355: 15391550.
  6. DiNardo AR, 2018. Diagnostic and treatment monitoring potential of a stool-based quantitative PCR assay for pulmonary tuberculosis. Am J Trop Med Hyg 99: 310316, doi:10.4269/ajtmh.18-0004.
  7. Oberhelman RA, 2015. A controlled study of tuberculosis diagnosis in HIV-infected and uninfected children in Peru. PLoS One 10: e0120915.
  8. Burman WJ, Reves RR, , 2000. Review of false-positive cultures for Mycobacterium tuberculosis and recommendations for avoiding unnecessary treatment. Clin Infect Dis 31: 13901395.
  9. de Boer AS, Blommerde B, de Haas PEW, Sebek MMGG, Lambregts-van Weezenbeek KSB, Dessens M, van Soolingen D, , 2002. False-positive Mycobacterium tuberculosis cultures in 44 laboratories in The Netherlands (1993 to 2000): incidence, risk factors, and consequences. J Clin Microbiol 40: 40044009.
  10. Steingart KR, Schiller I, Horne DJ, Pai M, Boehme CC, Dendukuri N, , 2014. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev 1: CD009593.
  11. Mayta H, 2003. Evaluation of a PCR-based universal heteroduplex generator assay as a tool for rapid detection of multidrug-resistant Mycobacterium tuberculosis in Peru. J Clin Microbiol 41: 57745777.
  12. Datta S, Shah L, Gilman RH, Evans CA, , 2017. Comparison of sputum collection methods for tuberculosis diagnosis: a systematic review and pairwise and network meta-analysis. Lancet Glob Health 5: e760e771.
  13. Chow F, Espiritu N, Gilman RH, Gutierrez R, Lopez S, Escombe AR, Evans CAW, Moore DAJ, , 2006. La cuerda dulce—a tolerability and acceptability study of a novel approach to specimen collection for diagnosis of paediatric pulmonary tuberculosis. BMC Infect Dis 6: 67.
  14. Paris L, 2017. Urine lipoarabinomannan glycan in HIV-negative patients with pulmonary tuberculosis correlates with disease severity. Sci Transl Med 9: eaal2807.
  15. Wolf H, 2008. Diagnosis of pediatric pulmonary tuberculosis by stool PCR. Am J Trop Med Hyg 79: 893898.
  16. Cordova J, 2010. Evaluation of molecular tools for detection and drug susceptibility testing of Mycobacterium tuberculosis in stool specimens from patients with pulmonary tuberculosis. J Clin Microbiol 48: 18201826.
  17. Oberhelman RA, 2010. Diagnostic approaches for paediatric tuberculosis by use of different specimen types, culture methods, and PCR: a prospective case-control study. Lancet Infect Dis 10: 612620.
  18. Nicol MP, Spiers K, Workman L, Isaacs W, Munro J, Black F, Zemanay W, Zar HJ, , 2013. Xpert MTB/RIF testing of stool samples for the diagnosis of pulmonary tuberculosis in children. Clin Infect Dis 57: e18e21.
  19. LaCourse SM, 2018. Stool Xpert MTB/RIF and urine lipoarabinomannan for the diagnosis of tuberculosis in hospitalized HIV-infected children. AIDS 32: 6978.
  20. Ramos E, 2010. Optimizing tuberculosis testing for basic laboratories. Am J Trop Med Hyg 83: 896901.
  21. Friedrich SO, Pan African Consortium for the Evaluation of Anti-tuberculosis Antibiotics (PanACEA) , 2013. Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment. Lancet. Respir Med 1: 462470.
  22. Datta S, Sherman JM, Bravard M, Valencia T, Gilman RH, Evans CA, , 2015. Clinical evaluation of tuberculosis viability microscopy for assessing treatment response. Clin Infect Dis 60: 11861195.
  23. Hellyer TJ, DesJardin LE, Teixeira L, Perkins MD, Cave MD, Eisenach KD, , 1999. Detection of viable Mycobacterium tuberculosis by reverse transcriptase-strand displacement amplification of mRNA. J Clin Microbiol 37: 518523.
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.18-0507
Loading
  • Received : 12 Jun 2018
  • Accepted : 14 Jun 2018

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error